Skip to main content

Author: Customer Service

Apexis, Inc. dba Wondersign, a GigaCloud Company, Launches Wonder App and Is Set to Rebrand as Wonder

Redefining Sales Enablement for Suppliers and Retail Sales Associates in the Brick-and-Mortar Market Ashley Furniture Leads as First Adopter EL MONTE, Calif., March 10, 2025 (GLOBE NEWSWIRE) — GigaCloud Technology Inc. (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that its subsidiary, Apexis, Inc., has launched the Wonder App—a mobile-first, lightweight sales acceleration platform designed for brick-and-mortar commerce. The app connects suppliers and retail sales associates (RSAs) by offering education, training, performance tracking and rewards, providing suppliers with instant insights into RSA activity and greater sales influence. “Brick-and-mortar retail is evolving rapidly, and suppliers must stay connected to their...

Continue reading

Belpointe OZ Announces Fourth Quarter 2024 Net Asset Value Per Class A Unit

GREENWICH, Conn., March 10, 2025 (GLOBE NEWSWIRE) — Belpointe PREP, LLC (NYSE American: OZ) (“Belpointe OZ,” “we,” “us,” “our” or the “Company”), a publicly traded qualified opportunity fund, today announced its unaudited quarterly net asset value (“NAV”) as of December 31, 2024, of $439,479,873 or $119.94 per Class A Unit. The approximately $22 increase in our unaudited quarterly NAV, from $97.93 as of September 30, 2024 to $119.94 as of December 31, 2024, is primarily due to updated valuations for Belpointe OZ’s Florida assets, reflecting continued progress across our portfolio. “Our flagship development, Aster & Links in Sarasota, FL, is making solid lease-up progress, contributing significantly to our increased valuation,” said Brandon Lacoff, CEO of Belpointe OZ. “Additionally, Viv, our development in St. Petersburg,...

Continue reading

Disclosure of transactions in on shares from March 03rd to March 07th, 2025

Nanterre, March 10th, 2025                       Disclosure of transactions in on shares from March 03rd to March 07th, 2025 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 09, 2024, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from March 03rd to March 07th, 2025: I – Aggregate presentation by day and by marketIssuer’s name Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares in Euro Market (MIC code)VINCI 2025-03-03 FR0000125486 37 107 110,613290 XPARVINCI 2025-03-03 FR0000125486 19 586 111,062815 CEUXVINCI 2025-03-03 FR0000125486 11...

Continue reading

Quanex Building Products Announces First Quarter 2025 Results and Reaffirms Full Year 2025 Guidance

Margin Expansion Realized on Consolidated BasisResults Lifted by Contribution from Tyman AcquisitionRealization of Cost Synergies from Tyman Acquisition Progressing Well$65 Million of Debt Repaid Since Closing Tyman Acquisition HOUSTON, March 10, 2025 (GLOBE NEWSWIRE) — Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended January 31, 2025.   The Company reported the following selected financial results:    Three Months Ended January 31,($ in millions, except per share data)   2025   2024Net Sales   $400.0   $239.2Gross Margin   $92.3   $51.4Gross Margin %   23.1%   21.5%Net (Loss) Income   ($14.9)   $6.2Diluted EPS   ($0.32)   $0.19         Adjusted Net Income   $9.0   $8.4Adjusted Diluted EPS   $0.19   $0.25Adjusted EBITDA   $38.5   $19.3Adjusted...

Continue reading

Barnes & Noble Education Reports Third Quarter Fiscal Year 2025 Financial Results

BNC First Day® Program Revenues Increased 21% YOY to $222 Million Total Revenue Growth of 2% and Gross Comparable Store Sales Growth of 7% Net Income Improves by $17 Million to $7 Million Adjusted EBITDA Improves by $6 Million to $27 Million BASKING RIDGE, N.J., March 10, 2025 (GLOBE NEWSWIRE) — Barnes & Noble Education, Inc. (NYSE: BNED), (“Barnes & Noble Education,” “BNED,” the “Company,” “we,” “us,” “our”), a leading solutions provider for the education industry, today reported sales and earnings for the third quarter ended on January 25, 2025 (“Q3”). The following figures are GAAP results from continuing operations on a consolidated basis, unless noted otherwise. Note that Adjusted EBITDA is a non-GAAP calculation. Full quarterly financial tables and a reconciliation of non-GAAP measures to the most applicable GAAP...

Continue reading

Great Elm Capital Corp. Announces Fourth Quarter and Full Year 2024 Financial Results

Company to Host Conference Call and Webcast at 8:30 AM ET on March 11, 2025 PALM BEACH GARDENS, Fla., March 10, 2025 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (“we,” “our,” the “Company” or “GECC”) (NASDAQ: GECC), a business development company, today announced its financial results for the fourth quarter and full year ended December 31, 2024.       Fourth Quarter and Other Recent HighlightsIn December 2024, the GECC raised $13.2 million of equity at Net Asset Value from Summit Grove Partners, LLC (“SGP”), supported by a $3.3 million investment by Great Elm Group, Inc. (“GEG”) in SGP. Net investment income (“NII”) for the quarter ended December 31, 2024 was $2.1 million, or $0.20 per share, as compared to $4.1 million, or $0.39 per share, for the quarter ended September 30, 2024.Timing of distributions from CLO Formation...

Continue reading

NCS Multistage Holdings, Inc. Announces Fourth Quarter and Full Year 2024 Results

Fourth Quarter ResultsTotal revenues of $45.0 million, a 28% year-over-year improvement Net income of $3.5 million and earnings per diluted share of $1.32, an improvement to the prior year period after adjusting for the non-cash benefit of legal settlement from one year ago Adjusted EBITDA of $8.2 million, compared to $2.5 million in the fourth quarter of 2023   $25.9 million in cash and $8.1 million in debt as of December 31, 2024Full Year ResultsTotal revenues of $162.6 million, a 14% improvement over 2023 Gross margin improved to 40% from 37% in 2023; Adjusted gross margin improved to 41% from 39% in 2023   Net income of $6.6 million and earnings per diluted share of $2.55, an improvement to the net loss of $(3.2) million and loss per share of $(1.27) in 2023 Adjusted EBITDA of $22.3 million, compared to $11.9 million in 2023 Cash...

Continue reading

Greenlight Re Announces Fourth Quarter and Year-End 2024 Financial Results

Grows Fully Diluted Book Value by 7.2% in 2024, Marking Fifth Consecutive Year of Book Value Growth; Increases Transparency with New Reporting Segments GRAND CAYMAN, Cayman Islands, March 10, 2025 (GLOBE NEWSWIRE) — Greenlight Capital Re, Ltd. (NASDAQ: GLRE) (“Greenlight Re” or the “Company”) today reported its financial results for the fourth quarter and year ended December 31, 2024. Effective December 31, 2024, the Company restructured its reportable segments to better align with its multi-pillar strategy. Moving forward, the Company will report financial results under two segments, Open Market and Innovations. Additionally, prior-period results have been revised to ensure consistency with the new reporting structure. Fourth Quarter 2024 Highlights (all comparisons are to fourth quarter 2023 unless noted otherwise):Gross premiums...

Continue reading

Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update

– Annual net revenue increased 4% to $267.0 million in 2024, despite significant divestitures –– UDENYCA® net revenue increased 62% year-over-year –– LOQTORZI® net revenue increased 29% quarter-over-quarter – – UDENYCA divestiture on track with Special Meeting of Shareholders taking place March 11, 2025; transaction expected to close late in the first quarter or early in the second quarter of 2025 – – Post divestiture expected cash of approximately $250 million, with cash runway exceeding two years; Company headcount to be reduced by approximately 30% – – Catalyst-driven 2025/2026 with multiple clinical data readouts across the Company’s innovative oncology pipeline – – Conference call today at 5:00 p.m. Eastern Time – REDWOOD CITY, Calif., March 10, 2025 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus or the Company, Nasdaq:...

Continue reading

OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

— PIKture-01 trial update including additional PK data, mature single agent and initial combination data expected in the second half of 2025; reported encouraging preliminary data in December 2024 — Expansion of PI3Ka franchise to include a pan-mutant selective program; development candidate expected to be announced in Q2 2025 — $111M in cash and cash equivalents expected to be sufficient to fund operations through multiple PIKture-01 clinical readouts and anticipated milestones into Q4 2026 BOULDER, Colo., March 10, 2025 (GLOBE NEWSWIRE) — OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on developing novel precision medicines in oncology, today reported financial results for the fourth quarter and full year ended December 31, 2024, and provided recent business highlights. “I am extremely...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.